Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.23 - $0.46 $2,809 - $5,618
-12,215 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$0.55 - $1.04 $676 - $1,279
-1,230 Reduced 9.15%
12,215 $7,000
Q3 2021

Nov 15, 2021

BUY
$1.06 - $1.52 $1,028 - $1,474
970 Added 7.78%
13,445 $14,000
Q2 2021

Aug 16, 2021

SELL
$1.22 - $1.65 $927 - $1,254
-760 Reduced 5.74%
12,475 $19,000
Q1 2021

May 12, 2021

BUY
$1.18 - $2.62 $2,312 - $5,135
1,960 Added 17.38%
13,235 $20,000
Q4 2020

Feb 16, 2021

BUY
$1.05 - $2.24 $11,838 - $25,256
11,275 New
11,275 $12,000

About iBio, Inc.


  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $20.9M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.